So Far, Just One Thing Has ‘Experimental Support’ In Staving Off Alzheimer’s

Scientists have made significant strides in the last two decades in understanding Alzheimer’s disease and learning more about who might be victimized by it, but they’ve suffered immense frustration by so many failed large clinical trials that they had hoped might treat it.

Read the full post on Forbes - Healthcare